or
forgot password

    • cancer clinical trials in ocala, FL

    • Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    Ocala Oncology Center
    Ocala, Florida 34474
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Ocala Oncology Center
    Ocala, Florida 34474
    Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary
    The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer
    Florida Foundation for Healthcare Research
    Ocala, Florida 34474
    Prostate Cancer
    Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
    Ocala Oncology Center
    Ocala, Florida 34474
    Metastatic Breast Cancer
    Safety and Efficacy of Angiotech Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access
    Discovery Medical Research Group
    Ocala, Florida 34471
    Kidney Diseases, ESRD
    Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
    Ocala Oncology Center
    Ocala, Florida 34474
    Metastatic Breast Cancer
    Study to Evaluate Erlotinib With or Without SNDX-275 in the Treatment of Patients With Advanced NSCLC
    Ocala Oncology Center
    Ocala, Florida 34474
    Non-Small-Cell Lung Carcinoma, Carcinoma, Non-Small Cell Lung
    A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
    Ocala Oncology Center- US Oncology
    Ocala, Florida 34471
    Pancreatic Neoplasms
    Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma
    Ocala Cancer Institute
    Ocala, Florida 34471
    Relapsed Follicular Lymphoma
    A Trial of Degarelix in Patients With Prostate Cancer
    Florida Foundation for Healthcare Research
    Ocala, Florida 34474
    Prostate Cancer
    Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
    Urology Health Team, PLLC
    Ocala, Florida 34474
    Bladder Neoplasm, Intravesical Drug Administration, Neoplasm Recurrence, Local, Transitional Cell, Carcinoma, Carcinoma in Situ, Mycobacterium
    Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
    Ocala Oncology Center PL
    Ocala, Florida 34474
    Anemia, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small-Cell Lung, Bladder Cancer, Cancer of Head and Neck, Uterine Cervical Cancer